BioInvent International Aktiebolag
556537-7263ActiveClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Clinical-Stage Biotechnology Companybioinvent.com
Yleiskatsaus
- 100–199
- Työntekijät
- 20–50milj SEK
- Liikevaihto
- 1997
- Perustettu
Avainpäättäjät
Cecilia Hofvander
VP Investor Relations
@bioinvent.com+46462XXXXXX
Thomas Hecht
Member of the Board
@bioinvent.com
Andres McAllister
Chief Medical Officer
@bioinvent.com
Kristoffer Bissessar
Member of the Board
@bioinvent.com
+18 lisää yhteystietoja Funnelfeedrissä
Kuvaus
BioInvent is a clinical-stage biotechnology company focused on discovering and developing innovative antibody therapeutics for cancer treatment. The core of their work lies in leveraging deep expertise in immunology, cancer biology, and antibody biology to generate novel immuno-oncology drug candida...
CAEDO ONCOLOGY AS